Publication | Closed Access

The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease

Hematological MalignancyStable DiseaseLymphoid NeoplasiaMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunologyCell DeathAdult T-cell Leukemia-lymphomaImmunotherapyDifferent Proliferative CapacityCell BiologyCell SignalingCancer Research